Webinars & events

What do patent assignments, company mergers and the relocation of patent owners have in common? They all trigger the need for recordals to protect associated patent rights. On the 19 January 2021, we gather our Novagraaf experts to share recordals best practice with you.

As the Brexit transition period officially ended on 31 December 2020, the clock is ticking to find out what this means for your IP portfolio, as well as any actions you may need to take. Watch the recording of our latest Brexit webinar for timely advice on safeguarding your IP strategies and minimising business risk.

Listen to European patent filing and prosecution experts from across the IP community as they discuss the why, where and how to manage EP validations, including how you could manage your EP strategy easily and more cost effectively.

Global trademark management can be complicated and that's why we created our EasyIP IP management portal. In this 15-minute webinar, we cover how Novagraaf can help you to drive efficiencies and save significant costs using our trademark tools and services.

Watch our latest webinar on the management of global patent annuities using NovumIP Platform Solutions. In this 15-minute overview, we also introduce our new Annuities Portal.

Watch our webinar from 28 May 2020 for best practices on how to approach trademark portfolio management decisions and effectively avoid issues that could lead to enforcement risks and greater costs down the road.

On 7 May, we brought together a team of experts to discuss how to effectively manage patent portfolios at this time of crisis, remote working and increasing pressure on budgets.

For our Online Brand Protection webinar, we brought together a team of experts to explore the risks and opportunities posed to both brands and consumers online, in general and also in the context of new threats caused by our transition to remote working.

First broadcasted on 13 March 2019, this webinar will explain the status of Brexit negotiations (as of 13 March) and the plans that have been put in place for the cloning of IP rights (including in a ‘no-deal’ scenario).